Social Innovation in Engineering for Climate-Neutral Cities
Summary
This study aims to understand how people think about about civil infrastructure investments. Participants will complete one (or both) of two computer games that explore bicycle network improvements and water conservation practices, respectively. Responses will be used to plan and manage civil infrastructure in Calgary that better matches the preferences of residents and supports sustainable and climate-neutral cities.
Eligibility
Eligible ages: 18 to 99
Accepts healthy participants: Yes
Inclusion criteria:
1. 18 years of age or older
2. Able to read and speak basic English
3. Available to participate in the study in person at the University of Calgary. The study session will take approximately 60 minutes. Sessions may be scheduled between 9:00 AM and 8:00 PM.
Exclusion criteria:
There are no restrictions on participation in the study beyond those listed under the eligibility criteria. Every effort will be made to accomodate accessibility needs by participants, but games are designed assuming no visual impairments. There is no audio associated with either game.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Please contact Dr. Jason Hawkins.
Principal investigator:
Jason Hawkins
Clinical trial:
No
REB-ID:
REB26-0699